Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) Cost of Revenue (2019 - 2025)

Harte Hanks (HHS) has disclosed Cost of Revenue for 7 consecutive years, with $12.4 million as the latest value for Q2 2025.

  • On a quarterly basis, Cost of Revenue changed N/A to $12.4 million in Q2 2025 year-over-year; TTM through Jun 2025 was $58.0 million, a N/A change, with the full-year FY2024 number at $56.6 million, down 4.91% from a year prior.
  • Cost of Revenue was $12.4 million for Q2 2025 at Harte Hanks, down from $14.8 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $16.4 million in Q4 2023 to a low of -$35.9 million in Q4 2021.
  • A 5-year average of $10.4 million and a median of $14.0 million in 2022 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: crashed 305.83% in 2021, then skyrocketed 143.93% in 2022.
  • Harte Hanks' Cost of Revenue stood at -$35.9 million in 2021, then surged by 143.93% to $15.8 million in 2022, then increased by 4.13% to $16.4 million in 2023, then dropped by 9.85% to $14.8 million in 2024, then fell by 16.18% to $12.4 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Cost of Revenue are $12.4 million (Q2 2025), $14.8 million (Q4 2024), and $14.4 million (Q3 2024).